2-[(2S)-[(1S)-[(TERT.-BUTOXYCARBONYL)-AMINO]-2-PHENYL-ETHYL]-5-OXOPIPERAZIN-1-YL]-ACETIC-ACID
Compound with spectra: 1 NMR
![2-[(2S)-[(1S)-[(TERT.-BUTOXYCARBONYL)-AMINO]-2-PHENYL-ETHYL]-5-OXOPIPERAZIN-1-YL]-ACETIC-ACID](/api/compound/Eg9on9vwWev.png?ph=true&h=300&w=458 "2-[(2S)-[(1S)-[(TERT.-BUTOXYCARBONYL)-AMINO]-2-PHENYL-ETHYL]-5-OXOPIPERAZIN-1-YL]-ACETIC-ACID")
| SpectraBase Compound ID | Eg9on9vwWev |
|---|---|
| InChI | InChI=1S/C19H27N3O5/c1-19(2,3)27-18(26)21-14(9-13-7-5-4-6-8-13)15-10-20-16(23)11-22(15)12-17(24)25/h4-8,14-15H,9-12H2,1-3H3,(H,20,23)(H,21,26)(H,24,25)/t14-,15-/m0/s1 |
| InChIKey | MNHCTIVRJJIUNG-GJZGRUSLSA-N |
| Mol Weight | 377.44 g/mol |
| Molecular Formula | C19H27N3O5 |
| Exact Mass | 377.195071 g/mol |
| Enantiomer InChIKey | MNHCTIVRJJIUNG-HUUCEWRRSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(2R,3R/2S,3S)-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-PHENYLALANYL]-AZIRIDINE-2,3-DICARBOXYLIC-ACID
N-[N-(TERT.-BUTOXYCARBONYL)-L-PHENYLALANYL-(BETA-O-ACETYL)-L-SERYL]-O-TERT.-BUTYL-L-ALANIN
Heptanoic acid, (3RS,4S)-4-[(t-butoxycarbonyl-(R)-phenylalanyl-(S)-alanyl)amino]-3,6-dimethyl-, ethyl ester
(2S,3R,4R,5S)-2-BENZYL-5-((TERT.-BUTOXYCARBONYL)-AMINO)-3,4-EPOXY-6-PHENYLHEXYL-ACETATE
(2R,3S,4S,5S)-2-BENZYL-5-((TERT.-BUTOXYCARBONYL)-AMINO)-3,4-EPOXY-6-PHENYLHEXYL-ACETATE
N-[N-(TERT.-BUTOXYCARBONYL)-L-PHENYLALANYL-L-SERYL]-O-TERT.-BUTYL-L-VALIN
METHYL-N-(BENZYLOXYCARBONYL)-PHENYLALANYLLEUCYLLEUCINE
JVTKCLULJTUNEI-VPEKBSMISA-N
O,N-permethylated phe-gly-phe-gly
| Title | Journal or Book | Year |
|---|---|---|
| Exploring the Phe-Gly Dipeptide-Derived Piperazinone Scaffold in the Search for Antagonists of the Thrombin Receptor PAR1 | Molecules | 2014 |